Semiautomatic algorithm for lymph node analysis corrected for partial volume effects in combined positron emission tomography-computed tomography

Molecular Imaging

Volumn 9, Issue 6, 2010, Pages 319-328

  Bundschuh, Ralph A ^a   Essler, Markus ^a   Dinges, Julia ^a   Berchtenbreiter, Christian ^a   Mariss, Jan ^a   Martínez Möller, Axel ^a   Delso, Gaspar ^a   Hohberg, Melanie ^a   Nekolla, Stephan G ^a   Schulz, Dominik ^a   Ziegler, Sibylle I ^a   Schwaiger, Markus ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BENIGN LESION; COMPUTED TOMOGRAPHY; CT IMAGE; F-FLUORODEOXYGLUCOSE; FUNCTIONAL PARAMETERS; HIGH RESOLUTION; LESION VOLUME; LYMPH NODE; MALIGNANT LESION; MANUAL INTERACTION; MULTI-MODAL; PARTIAL VOLUME EFFECT; PARTIAL VOLUMES; QUANTITATIVE ANALYSIS; SEMI-AUTOMATIC ALGORITHMS; STAND -ALONE; STANDARDIZED UPTAKE VALUES; STRUCTURAL INFORMATION;

ALGORITHMS; BODY FLUIDS; COMPUTERIZED TOMOGRAPHY; POSITRONS;

POSITRON EMISSION TOMOGRAPHY;

FLUORODEOXYGLUCOSE F 18;

ALGORITHM; ARTICLE; AUTOMATION; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; HUMAN; IMAGE QUALITY; LYMPH NODE; METHODOLOGY; MIDDLE AGED; POSITRON EMISSION TOMOGRAPHY; RADIOGRAPHY; SCINTISCANNING;

ALGORITHMS; AUTOMATION; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; LYMPH NODES; MIDDLE AGED; PHANTOMS, IMAGING; POSITRON-EMISSION TOMOGRAPHY; TOMOGRAPHY, X-RAY COMPUTED;

EID: 78649752813     PISSN: 15353508     EISSN: None     Source Type: Journal    
DOI: 10.2310/7290.2010.00019     Document Type: Article

References (32)

1. Townsend DW, Carney JP, Yap JT, Hall NC. PET/CT today and tomorrow. J Nucl Med 2004;45 Suppl 1:4S-14S.
2. Lardinois D, Weder W, Hany TF, et al. Staging of non-small-cell lung cancer with integrated positron-emission tomography and computed tomography. N Engl J Med 2003;348:2500-7. (Pubitemid 36706537)
3. Weber WA, Figlin R. Monitoring cancer treatment with PET/CT: does it make a difference? J Nucl Med 2007;48 Suppl 1:36S-44S.
4. Kinahan PE, Townsend DW, Beyer T, Sashin D. Attenuation correction for a combined 3D PET/CT scanner. Med Phys 1998;25: 2046-53.
5. Beyer T, Antoch G, Muller S, et al. Acquisition protocol considerations for combined PET/CT imaging. J Nucl Med 2004; 45 Suppl 1:25S-35S.
6. Lammertsma AA, Hoekstra CJ, Giaccone G, Hoekstra OS. How should we analyse FDG PET studies for monitoring tumour response? Eur J Nucl Med Mol Imaging 2006;33 Suppl 1:16-21.
7. Weber WA, Ott K, Becker K, et al. Prediction of response to preoperative chemotherapy in adenocarcinomas of the esophagogastric junction by metabolic imaging. J Clin Oncol 2001;19:3058-65.
8. Bar-Shalom R, Valdivia AY, Blaufox MD. PET imaging in oncology. Semin Nucl Med 2000;30:150-85.
9. Prauer HW, Weber WA, Romer W, et al. Controlled prospective study of positron emission tomography using the glucose analogue [18f]fluorodeoxyglucose in the evaluation of pulmonary nodules. Br J Surg 1998;85:1506-11.
10. Larson SM, Erdi Y, Akhurst T, et al. Tumor treatment response based on visual and quantitative changes in global tumor glycolysis using PET-FDG imaging. The visual response score and the change in total lesion glycolysis. Clin Positron Imaging 1999;2:159-71.
11. Roedl JB, Halpern EF, Colen RR, et al. Metabolic tumor width parameters as determined on PET/CT predict disease-free survival and treatment response in squamous cell carcinoma of the esophagus. Mol Imaging Biol 2009;11:54-60.
12. Astner ST, Dobrei-Ciuchendea M, Essler M, et al. Effect of (11)Cmethionine- positron emission tomography on gross tumor volume delineation in stereotactic radiotherapy of skull base meningiomas. Int J Radiat Oncol Biol Phys 2008;72:1161-7.
13. Ciernik IF, Dizendorf E, Baumert BG, et al. Radiation treatment planning with an integrated positron emission and computer tomography (PET/CT): a feasibility study. Int J Radiat Oncol Biol Phys 2003;57:853-63.
14. Hoffman EJ, Huang SC, Phelps ME. Quantitation in positron emission computed tomography: 1. Effect of object size. J Comput Assist Tomogr 1979;3:299-308.
15. Soret M, Bacharach SL, Buvat I. Partial-volume effect in PET tumor imaging. J Nucl Med 2007;48:932-45.
16. Kessler RM, Ellis JR Jr, Eden M. Analysis of emission tomographic scan data: limitations imposed by resolution and background. J Comput Assist Tomogr 1984;8:514-22.
17. Hickeson M, Yun M, Matthies A, et al. Use of a corrected standardized uptake value based on the lesion size on CT permits accurate characterization of lung nodules on FDG-PET. Eur J Nucl Med Mol Imaging 2002;29:1639-47.
18. Jakoby B, Long M, Carr C, Townsend D. Physical performance of a new combined PET/CT scanner. J Nucl Med 2007;48:46P.
19. Teo BK, Seo Y, Bacharach SL, et al. Partial-volume correction in PET: validation of an iterative postreconstruction method with phantom and patient data. J Nucl Med 2007;48:802-10.
20. Rousset O, Rahmim A, Alavi A, Zaidi H. Partial volume correction strategies in PET. PET Clin 2007;2:235-49.
21. Seemann MD. Whole-body PET/MRI: the future in oncological imaging. Technol Cancer Res Treat 2005;4:577-82.
22. Delso G, Ziegler SI. PET/MR system design. Eur J Nucl Med Mol Imaging 2009;36 Suppl 1:S86-92.
23. Weissleder R, Elizondo G, Wittenberg J, et al. Ultrasmall superparamagnetic iron oxide: an intravenous contrast agent for assessing lymph nodes with MR imaging. Radiology 1990;175:494-8. (Pubitemid 20135291)
24. Guimaraes AR, Tabatabei S, Dahl D, et al. Pilot study evaluating use of lymphotrophic nanoparticle-enhanced magnetic resonance imaging for assessing lymph nodes in renal cell cancer. Urology 2008;71:708-12.
25. 18Ffluoro- 2-deoxy-D-glucose-positron emission tomography/computed tomography in non-small-cell lung cancer for prediction of pathologic response and times to relapse after neoadjuvant chemoradiotherapy. Clin Cancer Res 2006;12:97-106.
26. Weber WA, Ziegler SI, Thodtmann R, et al. Reproducibility of metabolic measurements in malignant tumors using FDG PET. J Nucl Med 1999;40:1771-7.
27. Bakheet SM, Powe J, Ezzat A, Rostom A. F-18-FDG uptake in tuberculosis. Clin Nucl Med 1998;23:739-42.
28. Gupta N, Gill H, Graeber G, et al. Dynamic positron emission tomography with F-18 fluorodeoxyglucose imaging in differentiation of benign from malignant lung/mediastinal lesions. Chest 1998;114:1105-11.
29. 18F-FDG PET for the evaluation of pulmonary nodules. J Nucl Med 2002;43:871-5.
30. Alkhawaldeh K, Bural G, Kumar R, Alavi A. Impact of dual-timepoint (18)F-FDG PET imaging and partial volume correction in the assessment of solitary pulmonary nodules. Eur J Nucl Med Mol Imaging 2008;35:246-52.
31. Benz MR, Allen-Auerbach MS, Eilber FC, et al. Combined assessment of metabolic and volumetric changes for assessment of tumor response in patients with soft-tissue sarcomas. J Nucl Med 2008;49:1579-84.
32. Juweid ME, Stroobants S, Hoekstra OS, et al. Use of positron emission tomography for response assessment of lymphoma: consensus of the Imaging Subcommittee of International Harmonization Project in Lymphoma. J Clin Oncol 2007;25: 571-8.